Nuvectra Corp. (NVTRQ)
OTOTC · Common · CUSIP 67075N108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NVTRQ and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
67075N108
Market Cap
Micro Cap · $67 Million
Previous Symbol
NVTR (changed 11/22/2019)
Previous Name
QiG Group LLC
Business: Nuvectra Corp. is a neurostimulation company committed to helping physicians improve the lives of people with chronic neurological conditions. The Algovita Spinal Cord Stimulation (SCS) System is the Companys first commercial offering and is CE marked and FDA approved for the treatment of chronic pain of the trunk and/or limbs. Its innovative technology platform also has capabilities under development to support other neurological indications such as sacral nerve stimulation (SNS), and deep brain stimulation (DBS).
Notes: March 14, 2016 -- Nuvectra Corp. (NASDAQ:NVTR), formerly QIG Group, LLC, announced today the completion of its spin-off from Greatbatch, Inc. (NYSE:GB) into an independent, publicly-traded neurostimulation medical device company. Nuvectra shares commenced regular way trading today on the NASDAQ Global Market under the symbol NVTR. he spinoff was accomplished by the distribution of all shares of Nuvectra’s common stock to Greatbatch’s stockholders on the basis of one share of Nuvectra common stock for every three shares of Greatbatch common stock held on March 7, 2016, the record date of the distribution.

Company Contact

CEO
Scott F. Drees
CFO
Walter Berger
Headquarters
5830 Granite Parkway, Suite 1100, Plano, TX 75024
Phone
972-668-4107 · Toll-Free 844-727-7897
Investor Relations
Nick Laudico, The Ruth Group · 646-536-7030 · nlaudico@theruthgroup.com
General Email
Investors@nuvectramed.com
SEC EDGAR Filings
View filings »